Joncker Nathalie T, Marloie Marie-Annick, Chernysheva Anna, Lonchay Christophe, Cuff Simone, Klijanienko Jerzy, Sigal-Zafrani Brigitte, Vincent-Salomon Anne, Sastre Xavier, Lantz Olivier
Laboratoire d'Immunologie, Institut Curie, 26 rue d'Ulm, 75005 Paris, France.
Int J Cancer. 2006 Mar 1;118(5):1205-14. doi: 10.1002/ijc.21472.
Tumor infiltrating lymphocytes (TIL) display activation markers and their presence is often associated with a favorable outcome. The role of tumor antigens in T cell recruitment into tumors is unclear. In an attempt to address this issue, we purified lymphocytes from breast tumor or nontumor, mammary tissue from patients, and normal mammary tissue from healthy individuals. In all groups, including healthy individuals, the majority of cells displayed an effector/memory (CD45RA(lo)/CD27(+/-)) phenotype and quite surprisingly the early and transient activation marker CD69, thus, questioning the tumor antigen specificity of TIL. Because the human repertoire is diverse, the T cells found in the tumors could recognize both self/tumor and environmental antigens through cross-reactivity. To test this hypothesis, we used two anti-male HY monospecific TCR transgenic mouse models. We found an infiltration of HY negative tumors by the CD4(+) and CD8(+) monoclonal T cells after priming with HY positive cells in the periphery. Thus, the presence of activated effector/memory T lymphocytes in tumors can be independent of reactivity against tumor antigens. These results suggest that to find activated effector T cells in a tissue does not always mean that a specific immune response is taking place.
肿瘤浸润淋巴细胞(TIL)表达激活标志物,其存在通常与良好预后相关。肿瘤抗原在T细胞募集到肿瘤中的作用尚不清楚。为了解决这个问题,我们从患者的乳腺肿瘤或非肿瘤乳腺组织以及健康个体的正常乳腺组织中纯化淋巴细胞。在所有组中,包括健康个体,大多数细胞表现出效应/记忆(CD45RA(lo)/CD27(+/-))表型,并且非常令人惊讶的是还表达早期和瞬时激活标志物CD69,因此,对TIL的肿瘤抗原特异性提出了质疑。由于人类的T细胞受体库是多样的,在肿瘤中发现的T细胞可能通过交叉反应识别自身/肿瘤和环境抗原。为了验证这一假设,我们使用了两种抗雄性HY单特异性TCR转基因小鼠模型。我们发现,在外周用HY阳性细胞致敏后,CD4(+)和CD8(+)单克隆T细胞会浸润HY阴性肿瘤。因此,肿瘤中活化的效应/记忆T淋巴细胞的存在可能与针对肿瘤抗原的反应性无关。这些结果表明,在组织中发现活化的效应T细胞并不总是意味着正在发生特异性免疫反应。